SEC Form D · Amendment · filed July 29, 2025
Artax Biopharma, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (26)
Robert M. Armstrong, Ph.D · Cambridge, MAExec · DirectorDamia M. Tormo, Ph.D · Cambridge, MADirectorCasper W. Breum · Cambridge, MADirectorGino M. Santini · Cambridge, MADirectorAndre W. Hoekema · Cambridge, MADirectorRaj W. Parekh · Cambridge, MADirectorMaria W. Nichol · Cambridge, MAExecAlan E. Walts · Cambridge, MADirectorKen Deregt · New York, NYExec · DirectorAndre W. Hoekema · Cambridge, MADirectorEdwin Kania · LOS ANGELES, CADirectorMaria W. Nichol · Cambridge, MAExecIan Leaman · El Segundo, CADirectorScott Stout · El Segundo, CADirectorQuentin Yarie · Toronto, Ontario, CanadaDirectorDrew Anwyll · Toronto, Ontario, CanadaDirectorJoe W. Suarez · Cambridge, MAExecArne Brock-Utne · Lafayette, CADirectorRami Elghandour · Gaithersburg, MDExec · DirectorDavid T. Lubner · Gaithersburg, MDDirectorAlan Young · Detroit, MIDirectorCraig Brede · Englewood, CODirectorPhilip Fukushima · HONOLULU, HIDirectorLarry Tiffany · Riverdale, MDDirectorMichael Bucella · Miami, FLExecJoe W. Suarez · Cambridge, MAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗